DATADOSE, LLC

An intelligent dosing platform system for emergency medication administration comprising intelligent injection devices with emergency protocol modules, time-based tracking systems, and AI-driven prompting systems. The system analyzes time-based administration protocols for emergency medications, monitors elapsed time since previous medication administrations, and generates next dose prompts based on protocol timing requirements and elapsed time data. A field coordination module transmits administration timing data between field emergency response teams and remote coordination systems. The system supports emergency response environments including cardiac emergencies, anaphylaxis, opioid overdose response, and military field operations. Multi-modal alert systems deliver dose prompts through audible alerts, visual electronic medical record prompts, and remote physician communications. The system prevents duplicate medication administration across emergency response teams through timing data sharing while accounting for time delays caused by patient movement and transport.

An intelligent dosing platform system for device lifecycle management and predictive maintenance comprising intelligent injection devices with sensors configured to detect operational parameters, device monitoring modules tracking sensor calibration state, battery life metrics, and device performance data. A predictive analytics module analyzes device operational data to forecast maintenance timing, sensor calibration requirements, and device replacement needs. The system includes maintenance scheduling modules that generate automated maintenance alerts based on predicted device performance degradation. A lifecycle documentation module maintains comprehensive device history records including deployment dates, calibration events, maintenance activities, and retirement tracking. The system optimizes device fleet performance through proactive maintenance scheduling, minimizes device downtime through predictive failure prevention, ensures patient safety through continuous device integrity monitoring, and maintains regulatory compliance through comprehensive lifecycle documentation and firmware management capabilities.

A device may analyze, by an artificial intelligence module of the intelligent dosing platform, a pattern in medication administration across a different geographic location to identify a location-based trend in pharmaceutical delivery. A device may identify, by the data fusion engine, a data package for commercial distribution to a third party based on the administration data and the location-based trend, wherein the data package comprises at least one of an aggregated data summary, a simulation result, or a prediction output. A device may package, by the data fusion engine, the identified data package into a commercial product. A device may make available, through the data marketplace interface, the commercial data product to the third party for a commercial transaction, wherein the third party is selected from a pharmaceutical entity, a healthcare provider entity, a healthcare payor entity, a regulatory authority entity, or a research organization entity.

An intelligent injection device may determine, by an intelligence analytics module based on a characteristic of the administration data, a reporting authority to whom the administration data should be reported. A device may determine, by the intelligence analytics module for the reporting authority, a reporting format appropriate to the reporting authority. A device may determine, by the intelligence analytics module, a reporting timing parameter for the reporting authority. A device may determine, by the intelligence analytics module, a necessary audit data element to be included in a report to the reporting authority. A device may generate, by a reporting module of the intelligent dosing platform, a report for the reporting authority based on the determined reporting format, the determined reporting timing parameter, and the determined necessary audit data element.

An intelligent dosing platform system for prior authorization and pharmacy benefit management comprising intelligent injection devices with prior authorization modules configured to receive medication release approval from pharmacies, distributing agents, and payor entities. The system analyzes authorization requirements by evaluating individual payor policies, pharmacy benefit manager formulary restrictions, step therapy requirements, medical necessity criteria, seasonality factors, and timing considerations. An automated decision engine determines authorization approval or denial based on real-time policy evaluation and aggregated device usage data from multiple injection devices. An action coordinator triggers downstream processes including preventing device shipment, updating electronic health records, and coordinating billing system updates. A financial reconciliation module ensures one-to-one correspondence between authorization approvals and fulfillment activities, matching approved medications with actually shipped or administered medications while preventing payment for unapproved medications.

An intelligent dosing platform system for medication authentication and anti-counterfeiting comprising intelligent injection devices with authentication modules, artificial intelligence modules, and fraud detection capabilities. The system utilizes multi-modal verification including visual recognition, RFID/NFC communication, and blockchain validation to authenticate medications and devices. An authentication module analyzes medication identification data to determine authenticity status, while an AI module generates authenticity scores based on visual recognition data, radio-frequency identification data, near-field communication data, and blockchain verification data. The fraud detection module identifies characteristics of counterfeit pharmaceuticals and fraudulent devices. A locking mechanism prevents medication administration when authentication scores fall below predetermined thresholds. The system maintains distributed ledger records tracking medication custody from manufacturers through distributors to patient administration points, protecting against supply chain tampering and unauthorized medication sources.

A device may maintain, by a governance module of an intelligent dosing platform, a governance library comprising an operation rule and a criterion regarding appropriate use of an intelligent injection device. A device may create, by a digital twin module of the intelligent dosing platform, a digital twin embodiment. A device may generate, by an intelligence analytics module of the intelligent dosing platform based on the governance library operation rule and the criterion and the digital twin embodiment, a personnel training protocol tailored to a specific personnel role. A device may deliver, through a training system of the intelligent dosing platform, an interactive training experience. A device may monitor, by the intelligence analytics module, personnel training performance. A device may calculate, by an artificial intelligence module of the intelligent dosing platform, a training competency score based on conformance of trainee performance to the governance library operation rule and the criterion.

A device may receive, by an intelligence analytics module of an intelligent dosing platform at least one applicable governance standard from a governance library. A device may determine, by the intelligence analytics module based on the at least one applicable governance standard, at least one analysis type to be performed regarding the request. A device may execute, by an artificial intelligence module of the intelligent dosing platform, the at least one analysis type with respect to the request according to the at least one applicable governance standard. A device may generate, based on a result of the at least one analysis type, a determination regarding whether to permit the requested dosage administration or the requested device control decision, wherein the determination accounts for compliance with the at least one applicable governance standard.

A method, computer program product, and computer system for a platform for managing injectable medication administration reporting. The platform may include: a server configured to receive administration data from an intelligent injection device, a database configured to store treatment schedules, an artificial intelligence module configured to categorize injection events based on compliance with treatment schedules, and a reporting module configured to: generate detailed reports on patient adherence, automatically distribute reports to stakeholders, track patient outcomes, and facilitate management of healthcare documentation.

A method, computer program product, and computer system for a platform for managing injectable medication administration. The platform may include: a server configured to receive administration data from an intelligent injection device, a database configured to store treatment schedules, an artificial intelligence module configured to categorize injection events based on compliance with treatment schedules, and a user interface module configured to: provide control and configuration of the platform, automatically populate based on administration data from the injection device, display injection schedules and medication history, and enable management of healthcare documentation.